Correlation between pathology and neuromelanin MR imaging in Parkinson's disease and dementia with Lewy bodies

Neuroradiology

Volumn 55, Issue 8, 2013, Pages 947-953

  Kitao, Shinichiro ^a   Matsusue, Eiji ^b   Fujii, Shinya ^a   Miyoshi, Fuminori ^a   Kaminou, Toshio ^a   Kato, Shinsuke ^a   Ito, Hisao ^a   Ogawa, Toshihide ^a  

^a TOTTORI UNIVERSITY   (Japan)

^b Department of Thoracic and Cardiovascular Surgery   (Japan)

Author keywords

Dementia with Lewy bodies (DLB); MRI; Neuromelanin; Parkinson's disease (PD); Substantia nigra pars compacta (SNc)

Indexed keywords

FERRITIN; IRON; NEUROMELANIN;

AGED; ANALYTICAL PARAMETERS; ARTICLE; AUTOPSY; BRAIN NERVE CELL; BRAIN TISSUE; CASE REPORT; CELL DENSITY; CONTRAST SIGNAL RATIO; CORRELATION ANALYSIS; DIFFUSE LEWY BODY DISEASE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; IRON STORAGE; MALE; MESENCEPHALON; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PARKINSON DISEASE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SUBSTANTIA NIGRA PARS COMPACTA; THREE DIMENSIONAL IMAGING; TISSUE DISTRIBUTION; TISSUE FIXATION;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; FEMALE; HUMANS; IRON; LEWY BODY DISEASE; MAGNETIC RESONANCE IMAGING; MALE; MELANINS; PARKINSON DISEASE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STATISTICS AS TOPIC; SUBSTANTIA NIGRA;

EID: 84880844708     PISSN: 00283940     EISSN: 14321920     Source Type: Journal    
DOI: 10.1007/s00234-013-1199-9     Document Type: Article

References (18)

1. Marsden D (1965) Brain pigment and its relation to brain catecholamines. Lancet 10:475-76
2. Graham DG (1979) On the origin and significance of neuromelanin. Arch Pathol Lab Med 103:359-62
3. Bazelon M, Fenichel GM, Randall J (1967) Studies on neuromelanin: I. A melanin system in the human adult brainstem. Neurology 17:512-18
4. Enochs WS, Hyslop WB, Bennett HF et al (1997) Sources of the increased longitudinal relaxation rates observed in melanotic melanoma: an in vitro study of synthetic melanins. Invest Radiol 24:794-804
5. Enochs WS, Petherick P, Bogdanova A et al (1997) Paramagnetic metal scavenging by melanin: MR imaging. Radiology 204:417-23
6. Sasaki M, Shibata E, Tohyama K et al (2006) Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease. Neuroreport 17:1215-8
7. Nakane T, Nihashi T, Kawai H et al (2008) Visualization of neuromelanin in the substantia nigra and locus ceruleus at 1.5T using a 3D-gradient echo sequence with magnetization transfer contrast. Magn Reson Med Sci 7:205-10
8. McKeith IG, Galasko D, Kosaka K et al (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB International Workshop. Neurology 47:1113-24
9. McKeith IG, Dickson DW, Lowe J et al (2005) Consortium on DLB: diagnosis and management of dementia with Lewy bodies: third report of the DLB consortium. Neurology 65:1863-72
10. Schwarz ST, Rittman T et al (2011) T1-weighted MRI shows stage-dependent substantia nigra signal loss in Parkinson's disease. Movement Disorders 29:1633-38
11. Hallgren B, Sourander P (1958) The effect of age of the non/hemin iron in the human brain. J Neurochem 3:41-51
12. Vymazal J, Righini A, Brooks RA et al (1999) T1 and T2 in the brain of healthy subjects, patients with Parkinson disease, and patients with Parkinson disease, and patients with multiple system atrophy: relation of iron content. Radiology 211:489-95
13. Kinoshita T, Ogawa T, Yoshida Y et al (2005) Curvilinear T1 hyperintense lesions representing cortical necrosis after cerebral infarction. Neuroradiology 47:647-51
14. Castillo M, Scatliff JH, Kwock L et al (1996) Postmortem MR imaging of lobar cerebral infarction with pathologic and in vivo correlation. Radiographics 16:241-50
15. van den Hauwe L, Parizel PM, Martin JJ et al (1995) Postmortem MRI of the brain with neuropathological correlation. Neuroradiology 37:343-9
16. Tovi M, Ericsson A (1992) Measurements of T1 and T2 over time in formalin-fixed human whole-brain specimens. Acta Radiol 33:400-4
17. Kashihara K, Shinya T, Higaki F (2011) Neuromelanin magnetic resonance imaging of nigral volume loss in patients with Parkinson's disease. J Clin Neurosci 18:1093-6
18. Kashihara K, Shinya T, Higaki F (2011) Reduction of neuromelanin-positive nigral volume in patients with MSA, PSP and CBD. Intern Med 50:1683-7